Previous 10 | Next 10 |
home / stock / cvs / cvs articles
Amazon.com Inc’s (NASDAQ:AMZN) Prime RxPass subscription service has now expanded to over 50 million Medicare beneficiaries, enhancing afford...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigati...
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these b...
CVS Health Corporation (NYSE:PVH) shares closed slightly higher during Wednesday's session. On May 30, JPMorgan analyst Lisa Gill maintained C...
The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century. Economists are ...
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks...
CVS Health Corp. (NYSE:CVS) is reportedly seeking a private equity partner to fund the expansion of Oak Street Health, the $10.6 billion ...
UnitedHealth Group‘s (NYSE:UNH) OptumRx unit has a new pricing model to help manage drug costs for insurers. Starting next year, the Op...
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential secu...
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 06:35:00 ET CVS Health (NYSE: CVS) is a top pharmacy retailer in the U.S., and over the years, it has been expanding its operations to go deeper into healthcare. The stock also provides investors with a dividend that yields 4.3%, which is more than double the S&P 50...
2024-06-27 21:02:00 ET CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since November 2020. Pharmacy woes are continuing The pharmacy...
2024-06-20 08:00:10 ET Andrew Mok from Barclays issued a price target of $65.00 for CVS on 2024-06-20 07:01:00. The adjusted price target was set to $65.00. At the time of the announcement, CVS was trading at $61.01. The overall price target consensus is at $109.15 with ...